Galantamine Clinical Trials

• An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-Month Period
  ClinicalTrials.gov Identifier: NCT00299676 - Active, not recruiting
  Dementia; Alzheimer Disease; Galantamine
  
• Galantamine for Cognition in People With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00320736 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study
  ClinicalTrials.gov Identifier: NCT00216593 - Active, not recruiting
  Dementia; Alzheimer Disease
  
• A Study of Galantamine as an Adjunctive Treatment to Atypical Antipsychotics in Schizophrenia Patients with Cognitive Deficits
  ClinicalTrials.gov Identifier: NCT00077727 - Completed
  Schizophrenia
  
• The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning
  ClinicalTrials.gov Identifier: NCT00566735 - Active, not recruiting
  Major Depression; Bipolar Depression; Schizoaffective Disorder, Depressed Type
  
• A Double-Blind, Placebo-Controlled Study of Galantamine to Improve Cognitive Dysfunction in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00195845 - Active, not recruiting
  Bipolar Disorder
  
• An Open-Label Investigation of the Adjuvant Therapeutic Effects of Galantamine in Patients With Chronic Schizophrenia and Persistent Deficit Symptoms
  ClinicalTrials.gov Identifier: NCT00161044 - Active, not recruiting
  Chronic Schizophrenia
  
• Galantamine Executive Function in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00211588 - Active, not recruiting
  Parkinson's Disease
  
• Efficacy of Galantamine to Treat Schizophrenia
  ClinicalTrials.gov Identifier: NCT00232349 - Recruiting
  Schizophrenia; Psychotic Disorder
  
• The Use of Galantamine and CDP-Choline to Treat Adults With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00509067 - Recruiting
  Schizophrenia
  
• A Placebo Controlled Trial to evaluate the safety and efficacy of Galantamine in the treatment of vascular dementia
  ClinicalTrials.gov Identifier: NCT00035191 - Completed
  Dementia, Vascular
  
• Evaluation of Galantamine in the Treatment of Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00000172 - Completed
  Alzheimer Disease
  
• Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)
  ClinicalTrials.gov Identifier: NCT00523666 - Recruiting
  Alzheimer's Disease
  
• Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00082602 - Completed
  Alzheimer's Disease
  
• Galantamine in the Treatment of Post-Traumatic Headache
  ClinicalTrials.gov Identifier: NCT00219869 - Recruiting
  Post-Traumatic Headache; Head Trauma,Closed; Retention Disorders,Cognitive
  
• A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00181675 - Completed
  ADHD
  
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
  ClinicalTrials.gov Identifier: NCT00236431 - Completed
  Alzheimer Disease; Dementia
  
• A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
  ClinicalTrials.gov Identifier: NCT00236574 - Completed
  Alzheimer Disease; Dementia
  
• Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00176423 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Long-Term Safety and Efficacy of Galantamine in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00304629 - Completed
  Alzheimer Disease
  
• Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies
  ClinicalTrials.gov Identifier: NCT00230997 - Completed
  Lewy Body Disease
  
• An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.
  ClinicalTrials.gov Identifier: NCT00301574 - Completed
  Alzheimer Disease
  
• The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type
  ClinicalTrials.gov Identifier: NCT00216515 - Completed
  Alzheimer Disease
  
• An Observational Study of the Vital Status Data of Patients (Living or Deceased) Who Participated in Three Previous Studies of Galantamine for the Treatment of Mild Cognitive Impairment
  ClinicalTrials.gov Identifier: NCT00297414 - Completed
  Dementia
  
• A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00216502 - Completed
  Mental Disorders; Alzheimer Disease; Brain Diseases; Dementia
  
• A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00253188 - Completed
  Dementia; Alzheimer Disease
  
• A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00253201 - Completed
  Alzheimer Disease; Dementia
  
• A Study of the Safety and Effectiveness of a Flexible Dose of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00253227 - Completed
  Dementia; Alzheimer Disease
  
• Galantamine for Cognitive Deficits in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00463879 - Completed
  Schizophrenia
  
• A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
  ClinicalTrials.gov Identifier: NCT00240695 - Completed
  Mental Disorders; Cognition Disorder; Nervous System Diseases; Brain Diseases
  
• Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00338117 - Completed
  Alzheimer's Disease; Dementia
  
• Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation
  ClinicalTrials.gov Identifier: NCT00253214 - Completed
  Alzheimer Disease; Dementia
  
• A Study of the Safety and Effectiveness of Galantamine Hydrobromide (REMINYL®) in Patients With Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00297362 - Completed
  Brain Diseases; Alzheimer Disease; Mental Disorders; Nervous System Diseases; Dementia
  
• A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.
  ClinicalTrials.gov Identifier: NCT00309725 - Completed
  Alzheimer's Disease
  
• A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia
  ClinicalTrials.gov Identifier: NCT00261573 - Completed
  Alzheimer Disease; Vascular Dementia
  
• Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181636 - Completed
  Bipolar Disorder
  
• Effects on sleep and attention of two currently marketed drugs for Alzheimer's disease
  ClinicalTrials.gov Identifier: NCT00035204 - Completed
  Alzheimer's Disease
  
• A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
  ClinicalTrials.gov Identifier: NCT00416169 - Completed
  Pick Complex; Frontotemporal Dementia
  
• Treatment of Tardive Dyskinesia With Galantamine
  ClinicalTrials.gov Identifier: NCT00164242 - Completed
  Tardive Dyskinesia
  
• Galantamine Versus Placebo in Childhood Autism
  ClinicalTrials.gov Identifier: NCT00252603 - Completed
  Autism; Childhood Autism
  
• Galantamine Augmentation of Escitalopram for Treatment of Depression
  ClinicalTrials.gov Identifier: NCT00423969 - Terminated
  Depression
  
• Safety Study of Galantamine in Tic Disorders
  ClinicalTrials.gov Identifier: NCT00226824 - Terminated
  Tourette's Syndrome; Motor Tic Disorder; Vocal Tic Disorder